ClinicalTrials.gg
RecruitingNCT04236726CRF-QoLUpdated Jun 4, 2026

Investigating Health Related Quality of Life in Patients With Chronic Respiratory Failure

An observational study in Chronic Obstructive Pulmonary Disease, Respiratory Failure and Neuromuscular Diseases, sponsored by Guy's and St Thomas' NHS Foundation Trust. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-04.

Sponsored by Guy's and St Thomas' NHS Foundation Trust · Observational

From the registry’s dates

  • Started Dec 2019; still recruiting 6 years 10 months later.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
200
Ages
18 Years and older
Sex
All
01

Study summary

To determine the quality of life of patients living with chronic respiratory failure and the impact interventions have on it.

Read the detailed description

To determine the quality of life of patients living with chronic respiratory failure and the impact interventions have on it.

02

Conditions studied

  • Chronic Obstructive Pulmonary Disease
  • Respiratory Failure
  • Neuromuscular Diseases
  • Ventilatory Failure
03

In context

Pulmonary Disease, Chronic Obstructive

5,520 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 856 are open to participants now.

This study's planned enrollment of 200 is above the median of 158 across 1,497 observational studies indexed under Pulmonary Disease, Chronic Obstructive.

Browse Pulmonary Disease, Chronic Obstructive studies →

Lead sponsor

Guy's and St Thomas' NHS Foundation Trust is the lead sponsor of 295 studies on the registry; 80 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with chronic respiratory failure being treated with a form of ventilation of mechanical insufflation-exsufflation therapy.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Diagnosed with chronic respiratory failure receiving any of:

  • Non-invasive ventilation
  • Prolonged mechanical ventilation
  • Mechanical insufflation-exsufflation therapy

Exclusion criteria

Exclusion Criteria:

  • Aged \<18
  • Significant physical or psychiatric co-morbidity that would prevent compliance with trial protocol
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • Non-invasive ventilation

    Users of non-invasive ventilation

    Other: Questionnaire

  • Long term tracheostomy ventilation

    Long term tracheostomy ventilated patients

Interventions

  • OtherQuestionnaire

    HRQoL questionnaires

06

What researchers measure

Primary outcomes

  1. HRQoL score

    Outcome of various HRQoL assessment tools.

    Time frame: Day 0: At the first outpatient clinical consultation with the clinical team

Secondary outcomes

  1. Change in HRQoL score

    Change in HRQoL assessment tool score at next clinical follow-up.

    Time frame: 6 months following first assessment for Outcome 1

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Dec 2019 (actual). Primary completion is estimated for Dec 2026, 84 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 17, 2019
First posted
Jan 22, 2020
StartActual
Dec 19, 2019
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Jun 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04236726
Responsible party
Sponsor
First posted
Jan 22, 2020
Start date
Dec 19, 2019
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jun 4, 2026

Study contacts

Neeraj Shah, MBBS
Contact
neeraj.shah@gstt.nhs.uk
+442071888070
Patrick Murphy, MBBS
Contact
patrick.murphy@gstt.nhs.uk
+442071888070
Patrick Murphy, MBBS
study chair · Guy's and St Thomas' NHS Foundation Trust

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion